Sepsis & infection

Effects of IV Fluid Restriction According to Standard Fluid Treatment Intensity Across Conservative Versus Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC) Trial Sites

Crit Care MedPublished Secondary analysis of the CLASSIC randomised trial

Authors' conclusion

Among adult ICU patients with septic shock, variation in standard IV fluid volumes across sites did not substantially impact the effects of fluid restriction on outcomes after accounting for patient characteristics.

Study context

Population
Adult ICU patients with septic shock in CLASSIC trial sites with ≥15 participants in the standard-fluid group
Participants
1,366 patients · 19 sites
Comparison
Restrictive vs standard IV fluid therapy across site intensity subgroups
Methodological detailsmachine learning (eXtreme Gradient Boosting), hierarchical Bayesian models with weakly informative priors, site-level sensitivity analyses
  • Machine learning (eXtreme Gradient Boosting)
  • Hierarchical Bayesian models with weakly informative priors
  • Site-level sensitivity analyses

Primary result

As reported in the abstract

Mortality across five site intensity subgroups (subgroup) · day 90

Absolute differences in mortality across subgroups ranged from

−2.7% point to 1.4% point

Further findings

Administered minus predicted IV fluid volume, standard-fluid group · first 24 hours
−118 · median · IQR −1,341–1,731 · mL

Site-level sensitivity analyses

Results similar in the sensitivity analyses

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Effects of IV Fluid Restriction According to Standard Fluid Treatment Intensity Across Conservative Versus Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC) Trial Sites. Crit Care Med. Published 24 April 2025. doi:10.1097/ccm.0000000000006679

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.